For the first time in 30 years can be changed first-line therapy in Hodgkin’s lymphoma

Anticancer drug brentuximab vicodin (brentuximab vedotin), approved for the treatment of patients with relapsed and refractory Hodgkin’s lymphoma, may be included in the initial therapy of patients with advanced Hodgkin’s lymphoma. The results of the study ECHELON-1 was presented at the annual Continue reading “For the first time in 30 years can be changed first-line therapy in Hodgkin’s lymphoma”

Announcement: in Kazan will be held the V anniversary international school mammoplasty

In Kazan from 13 to 15 may 2018, will host the annual Big V jubilee international school for mammoplasty surgeons, mammologists, oncologists and plastic surgeons committed to excellence in plastic and aesthetic surgery of the breast. Leading experts will share their own case studies and examples Continue reading “Announcement: in Kazan will be held the V anniversary international school mammoplasty”